Cargando…

Clinical significance of CADM1/TSLC1/IgSF4 expression in Adult-T cell leukemia/lymphoma (ATLL): identification of various types of ATLL cells

Detalles Bibliográficos
Autores principales:	Nakahata, Shingo, Saito, Yusuke, Marutsuka, Kosuke, Hidaka, Tomonori, Maeda, Koichi, Utsunomiya, Atae, Okayama, Akihiko, Kubuki, Yoko, Shimoda, Kazuya, Asada, Yujiro, Ukai, Yoshinori, Kuosawa, Gene, Morishita, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112762/ http://dx.doi.org/10.1186/1742-4690-8-S1-A49

Ejemplares similares

Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-κB
por: Sarkar, Bidhan, et al.
Publicado: (2019)

Cumulative kinetics of epigenetic abnormalities during initiation and progression of Adult T-cell Leukemia/Lymphoma (ATLL)
por: Oka, Takashi, et al.
Publicado: (2011)

CCR4 drives ATLL jail break
por: Shannon, Kevin M.
Publicado: (2014)

Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
por: Uike, Naokuni, et al.
Publicado: (2011)

Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma
por: Nakahata, Shingo, et al.
Publicado: (2020)

Arsenic trioxyde in the treatment of HTLV1 associated ATLL
por: Suarez, Felipe, et al.
Publicado: (2011)

Neurolymphomatosis in patient with Adult T-cell leukaemia/lymphoma (ATLL)
por: Yoshimitsu, Maki, et al.
Publicado: (2015)

Baseline CD8 T-cell activation is not associated with survival in ATLL
por: Taylor, Graham P, et al.
Publicado: (2015)

NDRG2 plays a pivotal role in ATLL leukaemogenesis by regulating the PTEN-mediated PI3K/AKT signalling pathway
por: Nakahata, Shingo, et al.
Publicado: (2014)

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers
por: Nakahata, Shingo, et al.
Publicado: (2014)

A phase II study of lenalidomide in patients with relapsed or refractory ATLL
por: Phillips, Adrienne A, et al.
Publicado: (2014)

The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis
por: Moles, Ramona, et al.
Publicado: (2015)

HTLV-1, ATLL, refractory hypercalcaemia and HIV-1 co-infection
por: Laher, Abdullah E, et al.
Publicado: (2018)

Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets
por: Yoshida, Noriaki, et al.
Publicado: (2021)

The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis
por: Oliveira, Pedro Dantas, et al.
Publicado: (2022)

Live attenuated VZV vaccination induces antitumor immunity in ATLL patients
por: Jo, Tatsuro, et al.
Publicado: (2022)

ATLL introduction: is there a standard of care for treatment of adult T cell Leukemia Lymphoma?
por: Bazarbachi, Ali, et al.
Publicado: (2014)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014)

HTLV-1, ATLL, severe hypercalcaemia and HIV-1 co-infection: an overview
por: Laher, Abdullah Ebrahim, et al.
Publicado: (2018)

Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function
por: Nagate, Yasuhiro, et al.
Publicado: (2020)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
por: Rauch, Daniel A., et al.
Publicado: (2011)

Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2017)

Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL)
por: Xu, Xin, et al.
Publicado: (2020)

CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated Lysis
por: Manivannan, Kiruthika, et al.
Publicado: (2016)

HTLV-1 infection of Humanized SCID mice recapitulates Adult T-cell Leukemia/Lymphoma (ATLL) development
por: Banerjee, Prabal, et al.
Publicado: (2009)

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis
por: Vicario, Mattia, et al.
Publicado: (2018)

Exploration of mRNAs and miRNA classifiers for various ATLL cancer subtypes using machine learning
por: Ghobadi, Mohadeseh Zarei, et al.
Publicado: (2022)

Loss of CADM1/TSLC1 Expression Is Associated with Poor Clinical Outcome in Patients with Esophageal Squamous Cell Carcinoma
por: Zeng, De, et al.
Publicado: (2016)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
por: Hodson, Andrew, et al.
Publicado: (2011)

HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina
por: Mangano, Andrea, et al.
Publicado: (2014)

Guillain-Barré-like Syndrome, as a Rare Presentation of Adult T-cell Leukemia-Lymphoma (ATLL): A Case Report
por: Sasannejad, Payam, et al.
Publicado: (2012)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

130 Reinhard Kurth Honorary Lecture HTLV-I and Adult T Cell Leukemia/Lymphoma (ATLL): Cellular and Molecular Basis of Transformation
por: Hall, William W, et al.
Publicado: (2014)

Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis
por: Shafiee, Arman, et al.
Publicado: (2023)

Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus
por: Ghobadi, Mohadeseh Zarei, et al.
Publicado: (2023)

Proviral load does not discriminate patients with Human T-Cell Leukemia/Lymphoma (ATLL) from HTLV-1 carriers with a history of Strongyloidiasis
por: López, Giovanni, et al.
Publicado: (2011)

Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study
por: Zarei Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Mice transgenic for human CTLA4-CD28 fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells
por: Lee, Gyu Jin, et al.
Publicado: (2022)

Investigating the effect of MAP2K1 gene (MEK1) in MAPK pathway in the induction of adult T-cell leukemia/lymphoma (ATLL)
por: Hosseini, Parastoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t4adjv9qmbeo1d0mpok109thof